By Tom Winnifrith | Thursday 26 January 2017
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Apparently some folks think that Cloudtag (CTAG) is just a bad company not a fraud. I explain to such folks the difference between a fact and an opinion (Latin scholars are aware of this already) and why exactly that makes this company a 100% fraud. Its shares are now just 4.75p to sell but the target remains 0p as it is a fraud. Then it is on to the importance of NEDS and what they are there for ref Advanced Oncotherapy (AVO). Then I move to Ashley House (ASH) and a bit of macroeconomics, to Grand Group (GIPO) and onto Galantas Gold (GAL)